Erqi Pollom

Jacqueline J. Vallon, William Overman, Wanqiao Xu et al.

Over the past decade, the use of machine learning (ML) models in healthcare applications has rapidly increased. Despite high performance, modern ML models do not always capture patterns the end user requires. For example, a model may predict a non-monotonically decreasing relationship between cancer stage and survival, keeping all other features fixed. In this paper, we present a reproducible framework for investigating this misalignment between model behavior and clinical experiential learning, focusing on the effects of underspecification of modern ML pipelines. In a prostate cancer outcome prediction case study, we first identify and address these inconsistencies by incorporating clinical knowledge, collected by a survey, via constraints into the ML model, and subsequently analyze the impact on model performance and behavior across degrees of underspecification. The approach shows that aligning the ML model with clinical experiential learning is possible without compromising performance. Motivated by recent literature in generative AI, we further examine the feasibility of a feedback-driven alignment approach in non-generative AI clinical risk prediction models through a randomized experiment with clinicians. Our findings illustrate that, by eliciting clinicians' model preferences using our proposed methodology, the larger the difference in how the constrained and unconstrained models make predictions for a patient, the more apparent the difference is in clinical interpretation.

Sheng Liu, Oscar Pastor-Serrano, Yizheng Chen et al.

Objective: Radiotherapy treatment planning is a time-consuming and potentially subjective process that requires the iterative adjustment of model parameters to balance multiple conflicting objectives. Recent advancements in frontier Artificial Intelligence (AI) models offer promising avenues for addressing the challenges in planning and clinical decision-making. This study introduces GPT-RadPlan, an automated treatment planning framework that integrates radiation oncology knowledge with the reasoning capabilities of large multi-modal models, such as GPT-4Vision (GPT-4V) from OpenAI. Approach: Via in-context learning, we incorporate clinical requirements and a few (3 in our experiments) approved clinical plans with their optimization settings, enabling GPT-4V to acquire treatment planning domain knowledge. The resulting GPT-RadPlan system is integrated into our in-house inverse treatment planning system through an application programming interface (API). For a given patient, GPT-RadPlan acts as both plan evaluator and planner, first assessing dose distributions and dose-volume histograms (DVHs), and then providing textual feedback on how to improve the plan to match the physician's requirements. In this manner, GPT-RadPlan iteratively refines the plan by adjusting planning parameters, such as weights and dose objectives, based on its suggestions. Main results: The efficacy of the automated planning system is showcased across 17 prostate cancer and 13 head and neck cancer VMAT plans with prescribed doses of 70.2 Gy and 72 Gy, respectively, where we compared GPT-RadPlan results to clinical plans produced by human experts. In all cases, GPT-RadPlan either outperformed or matched the clinical plans, demonstrating superior target coverage and reducing organ-at-risk doses by 5 Gy on average (15 percent for prostate and 10-15 percent for head and neck).